欧州における動物医療市場動向および機会

Abstract

"Worth in excess of €4 billion, sales of animal health products in the European Union' s 27 member countries are responsible for well over a quarter of global market sales."

This report examines the size, structure and development of the EU market, and profiles the European operations of leading animal health product manufacturers.

Key coverage

• Learn the foundations and growth of the European Union, from its roots in 1950s to its recent expansion.
• Assess the market size, value, trends and forecasts for livestock and companion animal health products.
• Understand the variants in regional legislature and the affect of the Common Agricultural Policy.
• Examine national market profiles including major market segments and future market prospects.
• Review detailed profiles for the leading companies in the EU animal health market.

Market data

Regional market forecasts have been developed for the period up to 2011, based on the analysis of the main market drivers and constraints.

Detailed profiles for first and second tier markets enable you to track the regions you are already working in and help you to identify potential new growth areas.

Company performance data and market share is considered for the leading 13 animal health companies operating in the EU.

Key findings

The impact of the expanding EU on livestock populations and production on the structure of livestock farming and of trade flows.

Pet numbers and latest developments in the increasingly important companion animals market In depth examination of the market at a national and regional level.

The five leading companies operating in this sector generated aggregated sales of €2billion in 2006 with market shares set to be concentrated further in the next 5 years.

Products and companies covered

Companies covered:

Bayer, Boehringer Ingelheim, Ceva Elanco, Fort Dodge, Intervet, Merial Novartis, Pfizer, Pharmacia Animal Health, Schering-Plough Animal Health, Vetoquinol, Virbac.

Countries covered:

France, Germany, Spain, UK and Italy

Sectors covered:

Livestock, Companion animal

Who should read this report?

Job function:

Business Development, Marketing, Strategic Planning, Competitor Intelligence and Regulation.

Company types:

Animal Health Companies operating inside the EU or those looking to expand into the EU market. Manufacturers, distributors and suppliers of livestock, companion animal, agricultural and generics products.

Table of Contents

1. The European Union, including:

• Development of the European Union
• Goals, Institutions and the Legislative Process
• The Current EU
• Enlargement

2. Livestock Agriculture in the European Union:

• The Common Agricultural Policy
• Livestock Numbers, Production & Trade
• Factors Affecting Future Trends in EU Livestock Production
• Future Trends in EU Livestock Production

3. The EU Market for Animal Health Products:

• Market Size and Recent Growth
• Geography of the Market
• Market Structure by Product Category
• Factors Influencing Recent EU Market Growth
• Future Market Drivers and Constraints
• EU Market Forecasts to 2010

4. National Market Profiles:

• 1st Tier Markets, inc. France, Germany, Spain, UK and Italy
  • Market Size and Recent Growth
  • Major Market Segments
  • Future Market Prospects
• 2nd Tier Markets.

5. Leading Companies in the EU Animal Health Market:

• Concentration of the EU Market
• Leading Companies and Market Shares
• Company Profiles
  • Bayer
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Fort Dodge
  • Intervet
  • Merial
  • Novartis
  • Pfizer
  • Pharmacia Animal Health
  • Schering-Plough Animal Health
  • Vetoquinol
  • Virbac